Publication:

Pembrolizumab vs Placebo for Early-Stage Non.small-Cell Lung Cancer After Resection and Adjuvant Therapy: Subgroup Analysis of Patients Who Received Adjuvant Chemotherapy in the Phase 3 PEARLS/KEYNOTE-091 Study